LIN TAI-AN (Chief Scientific Officer) received a stock award from SPRINGWORKS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/4/2023ACC: 0001104659-23-106819
Officer· Chief Scientific Officer
Since Sep 2023
+99K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
99K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24K
Price / share
—
Trade value
—
% of position
New position
10/2/2023
0.00→24K
Total
Net shares
+24K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2023 | A · Award | +24K | — | — | New position | 0.00 | 24K |
| Total | +24K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
22.80
Held after
75K
Exercisable
—
10/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock75K shares | 10/2/2023 | A · Award | +75K | 22.80 | — | 75K |